Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9W69
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,312
Award facts
- Contract value 100% obligated
- $13,311.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,311.71 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on January 13, 2026, with completion expected by January 14, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions, and this order supports the military healthcare supply chain managed by DLA Troop Support Medical.
This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million and extending through December 2031. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and other medical supplies to military treatment facilities and federal healthcare systems. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, leverages this contract vehicle to fulfill critical pharmaceutical procurement requirements across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26F9W69?
SPE2DR26F9W69 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9W69 worth?
The government has obligated $13,312 on SPE2DR26F9W69.
Is contract SPE2DR26F9W69 an order under another contract?
Yes. SPE2DR26F9W69 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9W69 competed?
The extent of competition for SPE2DR26F9W69 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award